HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer

• Marc Arbyn,
• Ardashel Latsuzbaia,
• Philip E. Castle,
• Vikrant V. Sahasrabuddhe,
• Davy Vanden Broeck

Affiliations

Marc Arbyn

Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium; Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, University Ghent, Ghent 9000, Belgium; Corresponding author at: Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium.

Ardashel Latsuzbaia

Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium

Philip E. Castle

Division of Cancer Prevention, US National Cancer Institute, Rockville, MD 20850, USA; Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Rockville, MD 20850, USA

Vikrant V. Sahasrabuddhe

Division of Cancer Prevention, US National Cancer Institute, Rockville, MD 20850, USA

Davy Vanden Broeck

Department of Molecular Diagnostics (NRC HPV), AML Sonic Healthcare Belgium, Antwerp 2020, Belgium; International Centre for Reproductive Health, Faculty of Medicine and Health Sciences, Ghent University, Ghent 9000, Belgium